An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

Clinical trial NCT05928780 · UNKNOWN

Trial details

NCT number: NCT05928780
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2023-07-01
Primary completion: 2024-03-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.